Manufacture of basic pharmaceutical substances (PKD 21.10.Z)2007
Industry statistics (2025)
Number of companies
Companies
2,936
Companies (primary PKD)
184
Companies with financials
70
Business turnover
Legal structure
Legal formShare of companiesNumber of companies
- Sp. z o.o.72.3%133
- JDG10.3%19
- Sp. j.10.3%19
- S.A.3.3%6
- Sp. k.1.6%3
- P.S.A.1.1%2
- Other0.5%1
Financial results
Median revenue
Ranking
Median revenue compared with other PKD codes.
Top companies by revenue
| # | Company | Legal form | Revenue | Net profit |
|---|---|---|---|---|
| 1 | sp. z o.o. | USD 101.19m | USD 5.85m | |
| 2 | sp. z o.o. | USD 8.23m | USD 1.77m | |
| 3 | sp. z o.o. | USD 7.35m | USD 2.38m | |
| 4 | sp. z o.o. | USD 5.51m | USD 662.57k | |
| 5 | S.A. | USD 4.69m | USD 873.80k | |
| 6 | sp. j. | USD 4.14m | USD 141.39k | |
| 7 | sp. z o.o. | USD 2.24m | USD 98.73k | |
| 8 | sp. z o.o. | USD 2.19m | USD -1.86m | |
| 9 | sp. z o.o. | USD 2.04m | USD 8.52k | |
| 10 | sp. z o.o. | USD 1.97m | USD 134.27k |
Fastest-growing companies
| # | Company | Legal form | Revenue | Y/Y growth |
|---|---|---|---|---|
| 1 | sp. z o.o. | USD 1.80m | +530.7% y/y | |
| 2 | sp. z o.o. | USD 101.19m | +333.1% y/y | |
| 3 | sp. z o.o. | USD 7.35m | +80.7% y/y | |
| 4 | sp. z o.o. | USD 1.97m | +50.5% y/y | |
| 5 | sp. z o.o. | USD 757.63k | +36.8% y/y | |
| 6 | sp. z o.o. | USD 906.74k | +14.8% y/y | |
| 7 | sp. z o.o. | USD 1.03m | +14.1% y/y | |
| 8 | sp. z o.o. | USD 1.71m | +13.0% y/y | |
| 9 | sp. j. | USD 4.14m | +10.4% y/y | |
| 10 | sp. z o.o. | USD 414.89k | +8.8% y/y |
Stock market
No companies from this industry are listed.
Related PKD codes in division 21
FAQ
The primary industry for 184 companies is manufacture of basic pharmaceutical substances. 70 entities have filed financial statements.
In 2024, 5 new companies with PKD 21.10.Z were registered. In all of 2023, there were 8 such companies.
In 2025, the median revenue for PKD 21.10.Z was USD 170.34k and the mean revenue was USD 3.03m, based on 51 financial statements. Averages and medians include only companies that file financial statements, excluding sole proprietorships.
Yes, in 2025, the median net profit was USD 6.23k, an improvement on 2024 (USD 2.57k). Among all 626 industries in Poland, PKD 21.10.Z ranks 494th, placing it among the weakest 21%.
The most common legal form for PKD 21.10.Z is sp. z o.o., used by 133 companies in this industry (72.3% of the total). In second place is a sole proprietorship (19 companies, 10.3%), and in third place – sp. j. (19 companies, 10.3%).


